Evidence map›Paper›PMID 34199017›Full record

ArticleInternational journal of molecular sciences2021

Pharmacological Characterisation of

Bianca Op den Brouw, Parviz Ghezellou, Nicholas R Casewell, Syed Abid Ali, Behzad Fathinia, Bryan G Fry, Mettine H A Bos, Maria P Ikonomopoulou

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells.Environmental analysis, health and toxicology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 7 countries.

Bianca Op den BrouwVenom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia.ORCID 0000-0002-3650-5129
Parviz GhezellouMedicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran 1983969411, Iran.ORCID 0000-0001-5924-9618
Nicholas R CasewellCentre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.ORCID 0000-0002-8035-4719
Syed Abid AliH.E.J. Research Institute of Chemistry, International Centre for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi 75270, Pakistan.ORCID 0000-0003-0226-8257
Behzad FathiniaDepartment of Biology, Faculty of Science, Yasouj University, Yasouj 57914, Iran.ORCID 0000-0001-5752-9288
Bryan G FryVenom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia.ORCID 0000-0001-6661-1283
Mettine H A BosDivision of Thrombosis & Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-8164-817X
Maria P IkonomopoulouTranslational Venomics Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain.ORCID 0000-0001-7739-080X
The University of Queensland · AUJustus-Liebig-Universität Gießen · DELeiden University Medical Center · NLLiverpool School of Tropical Medicine · GBMadrid Institute for Advanced Studies · ESUniversity of Karachi · PKYasouj University · IR

Funding

Australian Research Council DP190100304National Institute for Medical Research Development 942485PDRF Phase II Batch-V NRPU No.20-3891TALENTO Program by the Regional Madrid Government 2018-T1/BIO-11262
6 · The paper itself

Abstract

Venoms are a rich source of potential lead compounds for drug discovery, and descriptive studies of venom form the first phase of the biodiscovery process. In this study, we investigated the pharmacological potential of crude

Indexed as

Antineoplastic AgentsBlood CoagulationCell Line, TumorCell SurvivalDose-Response Relationship, DrugFibrinolysisFibrinolytic AgentsHumansSerine Proteinase InhibitorsSnake VenomsViper VenomsAntineoplastic AgentsFibrinolytic AgentsSerine Proteinase InhibitorsSnake VenomsViper VenomsbiodiscoverycancercytotoxicEristicophisfibrinogenolysishaemotoxicmelanomaPseudocerastesthrombosisvenom

Identifiers

PMID34199017
PMCPMC8267730
OpenAlexW3176732197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.